• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

TNG:FP

11.0900 EUR 0.0700 0.64%

As of 11:35:00 ET on 04/15/2014.

Snapshot for Transgene SA (TNG)

Open: 11.0200 Day's Range: 10.9200 - 11.4900 Volume: 75,329
Previous Close: 11.0200 52wk Range: 8.0442 - 13.7100 1-Yr Rtn: +31.97%

Stock Chart for TNG

No chart data available.
  • TNG:FP 11.0900
  • 1D
  • 1M
  • 1Y
11.0200
Interactive TNG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TNG

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. CAC -
Earnings Per Share (EUR) (ttm) -1.3003
Est. EPS (EUR) (12/2014) -0.4800
Est. PEG Ratio -
Market Cap (M EUR) 426.17
Shares Outstanding (M) 38.43
30 Day Average Volume 126,023
Price/Book (mrq) 4.8159
Price/Sale (ttm) 95.0728
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/10/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TNG

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for TNG

Transgene S.A. is a biotechnology company. The Company develops vaccines against cancer and infectious diseases. Transgene has products under development for lung, kidney, prostate and colorectal cancers, cutaneous T-cell lymphoma, hepatitis C, malignant melanoma, and muscular dystrophy.

Philippe ArchinardChairman/CEOElisabeth KeppiDeputy CEO/Dir:Compliance
Stephane BoisselExecutive Vice PresidentLaurence BertaudDir:Human Resources
More Company Profile & Key Executives for TNG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil